2023. Effects of the use of semaglutide as a pharmacological option for weight loss in adults with BMI > 25 Kg/m²: a scoping review. Research, Society and Development. 12, 4 (Apr. 2023), e9012440955. DOI:https://doi.org/10.33448/rsd-v12i4.40955.